生殖内分泌与不孕症中的遗传学
综述遗传学进展对生殖内分泌与不孕症领域的影响,重点讨论胚胎植入前遗传学检测(PGT)用于非整倍体筛查、单基因病检测和结构重排排除,并提及囊胚期活检与二代测序等技术优化。
要点
- PGT可在胚胎移植前筛查非整倍体、检测单基因病或排除结构重排。
- 囊胚期活检较卵裂期活检有助于优化PGT结果。
- 二代测序使PGT更高效、更准确。
核心结论
- PGT方法的持续演进有潜力进一步提高结果准确性、扩展至其他病种,并通过降低成本和提升效率来增加可及性。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- PGT可对体外受精获得的胚胎在移植前进行筛查。
- PGT可用于非整倍体筛查、单基因病检测或结构重排排除。
- 在囊胚而非卵裂期获取样本有助于优化PGT结果。
- 二代测序等技术进步使PGT更高效、更准确。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tremendous advances in genetics have transformed the field of reproductive endocrinology and infertility over the last few decades. One of the most prominent advances is preimplantation genetic testing (PGT), which allows for the screening of embryos obtained during in vitro fertilization before transfer. Moreover, PGT can be performed for aneuploidy screening, detection of monogenic disorders, or exclusion of structural rearrangements. Refinement of biopsy techniques, such as obtaining samples at the blastocyst rather than the cleavage stage, has helped optimize results from PGT, and technological advances, including next-generation sequencing, have made PGT more efficient and accurate. The continued evolution of the approach to PGT has the potential to further enhance the accuracy of results, expand the application to other conditions, and increase access by reducing cost and improving efficiency.
引用
- Lee IT, Kappy M, Forman EJ, et al. Genetics in reproductive endocrinology and infertility. Fertil Steril. 2023. PMID: 36849035. doi:10.1016/j.fertnstert.2023.02.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。